Sep. 20, 2019—Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Sep. 19, 2019—A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
Sep. 19, 2019—Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.
Sep. 9, 2019—Vanderbilt's Master’s Program in Biomedical Sciences prepares students for a broad array of health professional careers.
Sep. 5, 2019—A team led by a neurosurgeon-scientist and an engineering professor who specializes in techniques for analyzing functional neuroimaging data has received a $3 million grant to study disturbances in brain networks related to attention lapses and cognitive deficits in patients with temporal lobe epilepsy.